IQVIA Holdings Inc (IQV)
234.79
-1.44
(-0.61%)
USD |
NYSE |
Sep 27, 16:00
234.70
-0.09
(-0.04%)
Pre-Market: 20:00
IQVIA Holdings SG&A Expense (Annual): 2.053B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.053B |
| December 31, 2022 | 2.071B |
| December 31, 2021 | 1.964B |
| December 31, 2020 | 1.789B |
| December 31, 2019 | 1.734B |
| December 31, 2018 | 1.716B |
| December 31, 2017 | 1.622B |
| Date | Value |
|---|---|
| December 31, 2016 | 1.016B |
| December 31, 2015 | 815.00M |
| December 31, 2014 | 781.00M |
| December 31, 2013 | 860.51M |
| December 31, 2012 | 817.76M |
| December 31, 2011 | 762.30M |
| December 31, 2010 | 698.41M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.734B
Minimum
2019
2.071B
Maximum
2022
1.922B
Average
1.964B
Median
2021
SG&A Expense (Annual) Benchmarks
| CVS Health Corp | -- |
| UNIVEC Inc | -- |
| First Physicians Capital Group Inc | 12.95M |
| SCWorx Corp | 2.720M |
| AirSculpt Technologies Inc | 102.38M |